10.1002/ejoc.201901060
European Journal of Organic Chemistry
FULL PAPER
1H), 2.15 (d, J = 12.1 Hz, 2H), 1.97 (s, 2H), 1.72 (d, J = 13.3 Hz, 4H),
1.63 (s, 2H), 1.45 (dd, J = 20.4, 12.0 Hz, 4H); 13C NMR (101 MHz,
CDCl3) δ 143.48, 128.21, 127.13, 127.09, 79.44, 79.03, 37.70, 36.58,
32.05, 31.89, 27.61, 27.52; MS-EI+: [M]+ calcd for C23H26O+, 318.1979,
found, 318.1984.
51.62, 34.79; HRMS (ESI): [M+Na]+ calcd for C22H21NNaO2+, 354.1465,
found, 354.1462.
4-(benzhydryl(methyl)amino)benzonitrile(5e): White solid, mp: 62–
66 °C , 25.3 mg (85%); 1H NMR (400 MHz, CDCl3) δ 7.45 (d, J = 8.0 Hz,
2H), 7.41 – 7.27 (m, 6H), 7.14 (d, J = 7.2 Hz, 4H), 6.75 (d, J = 8.1 Hz,
2H), 6.21 (s, 1H), 2.80 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 152.48,
139.39, 133.52, 128.73, 128.62, 127.78, 120.50, 112.27, 98.36, 66.59,
34.71; HRMS (ESI): [M+Na]+ calcd for C21H18N2Na+, 321.1362, found,
321.1354.
(((4-phenylbutan-2-yl)oxy)methylene)dibenzene (3j): Colorless oil,
24.1 mg (71%);1H NMR (400 MHz, CDCl3) δ 7.35 (d, J = 7.2 Hz, 4H),
7.30 (dd, J = 13.0, 7.2 Hz, 4H), 7.26 – 7.19 (m, 4H), 7.14 (t, J = 7.2 Hz,
1H), 7.09 (d, J = 7.5 Hz, 2H), 5.47 (s, 1H), 3.63 – 3.50 (m, 1H), 2.79 –
2.68 (m, 1H), 2.63 – 2.53 (m, 1H), 2.02-1.89 (m, 1H), 1.83-1.72 (m, 1H),
1.21 (d, J = 6.1 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 143.43, 142.88,
142.62, 128.47, 128.41, 128.37, 127.59, 127.52, 127.28, 127.06, 125.76,
80.79, 72.45, 38.73, 31.93, 19.92; HRMS (ESI): [M+Na]+ calcd for
C23H24ONa+, 339.1719, found, 339.1712.
ethyl 2-(benzhydryl(4-chlorophenyl)amino)acetate (5f): Colorless oil,
1
34.5 mg (91%); H NMR (400 MHz, CDCl3) δ 7.32 – 7.21 (m, 10H), 7.10
(d, J = 9.1 Hz, 2H), 6.63 (d, J = 9.1 Hz, 2H), 6.12 (s, 1H), 4.01-3.94 (m,
4H), 1.11 (t, J = 7.1 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 170.92,
147.46, 140.29, 129.16, 128.91, 128.68, 127.69, 123.19, 115.74, 67.69,
+
(oxybis(methanetriyl))tetrabenzene (3k): Colorless oil, 20.3 mg (58%);
1H NMR (400 MHz, CDCl3) δ 7.31 – 7.27 (m, 8H), 7.24 (t, J = 7.3 Hz, 8H),
7.20 – 7.17 (m, 4H), 5.32 (s, 2H); 13C NMR (101 MHz, CDCl3) δ 142.36,
128.52, 127.56, 127.41, 80.15; HRMS (ESI): [M+Na]+ calcd for
C26H22ONa+, 373.1563, found, 373.1552.
60.90, 50.73, 14.23; HRMS (ESI): [M+Na]+ calcd for C23H22ClNNaO2
402.1231, found, 402.1230.
,
N-benzyl-N-methyl-1,1-diphenylmethanamine (5g): Colorless oil, 23.2
mg (81%);1H NMR (400 MHz, CDCl3) δ 7.54 (d, J = 7.4 Hz, 4H), 7.44 (d,
J = 7.3 Hz, 2H), 7.39 – 7.30 (m, 6H), 7.28 (d, J = 7.9 Hz, 1H), 7.22 (t, J =
7.3 Hz, 2H), 4.51 (s, 1H), 3.54 (s, 2H), 2.11 (s, 3H); 13C NMR (101 MHz,
CDCl3) δ 143.16, 140.06, 128.73, 128.58, 128.34, 128.19, 127.04,
126.99, 75.61, 59.88, 40.42; HRMS (ESI): [M+H]+ calcd for C21H22N+,
288.1747, found, 288.1744.
diphenylmethanol (3l): White solid, mp: 65–68 °C , 15.6 mg (85%); 1H
NMR (400 MHz, CDCl3) δ 7.53-7.43 (m, 8H), 7.43-7.37 (m, 2H), 5.95 (s,
1H); 13C NMR (101 MHz, CDCl3) δ 143.94, 128.63, 127.70, 126.68,
76.40; MS-EI+: [M+] calcd for C13H12O+, 184.0883, found, 184.0879.
((((1R,2S,5R)-2-isopropyl-5-methylcyclohexyl)oxy)methylene)dibenz-
ene (3m): Colorless solid, , mp: 58–62 °C, 13.6 mg (44%); H NMR (400
N,N-dibenzyl-1,1-diphenylmethanamine (5h): Colorless oil, 25.0 mg
(69%); 1H NMR (400 MHz, CDCl3) δ 7.58 (t, J = 8.5 Hz, 8H), 7.52 – 7.33
(m, 12H), 5.14 (s, 1H), 3.74 (s, 4H); 13C NMR (101 MHz, CDCl3) δ 140.51,
139.69, 129.40, 128.79, 128.45, 128.25, 127.11, 126.97, 67.28, 53.81;
HRMS (ESI): [M+H]+ calcd for C27H26N+, 364.2060, found, 364.2058.
1
MHz, CDCl3) δ 7.48 – 7.13 (m, 10H), 5.52 (s, 1H), 3.14 (td, J = 10.4, 4.1
Hz, 1H), 2.43 – 2.30 (m, 1H), 2.24 – 2.09 (m, 1H), 1.66 – 1.53 (m, 2H),
1.41 – 1.30 (m, 1H), 1.28 – 1.18 (m, 1H), 0.98 – 0.82 (m, 9H), 0.44 (d, J
= 6.9 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 143.89, 142.61, 128.25,
128.12, 127.98, 127.44, 126.92, 126.74, 79.96, 75.94, 48.78, 40.46,
34.59, 31.52, 25.10, 22.93, 22.44, 21.36, 15.68; HRMS (ESI): [M+Na]+
calcd for C23H30ONaO+, 345.2189, found. 345.2178.
4-benzhydrylmorpholine (5i): Colorless oil, 17.5 mg (69%); 1H NMR
(400 MHz, CDCl3) δ 7.42 (d, J = 7.3 Hz, 4H), 7.26 (t, J = 7.6 Hz, 4H),
7.17 (t, J = 7.3 Hz, 2H), 4.19 (s, 1H), 3.73 – 3.66 (m, 4H), 2.42 – 2.33 (m,
4H);13C NMR (101 MHz, CDCl3) δ 142.45, 128.64, 128.06, 127.14, 79.62,
67.32, 52.79; HRMS (ESI): [M+H]+ calcd for C17H20NO+, 254.1539, found,
254.1536.
N-benzhydryl-4-chloroaniline (5a): Colorless oil, 23.4 mg (80%); 1H
NMR (400 MHz, CDCl3) δ 7.36 – 7.21 (m, 10H), 7.04 (d, J = 8.8 Hz, 2H),
6.45 (d, J = 8.8 Hz, 2H), 5.44 (s, 1H), 4.27 (s, 1H); 13C NMR (101 MHz,
CDCl3) δ 145.91, 142.57, 129.09, 128.96, 127.66, 127.54, 122.53,
114.78, 63.28; HRMS (ESI): [M+H]+ calcd for C19H17ClN+, 294.1044,
found, 294.1035.
2-benzhydryl-1,2,3,4-tetrahydroisoquinoline (5j): White solid, mp: 80–
84 °C , 21.8 mg (73%); 1H NMR (400 MHz, CDCl3) δ 7.64 (d, J = 7.5 Hz,
4H), 7.45 (t, J = 7.5 Hz, 4H), 7.35 (t, J = 7.4 Hz, 2H), 7.31 – 7.19 (m, 3H),
7.04 (d, J = 7.4 Hz, 1H), 4.58 (s, 1H), 3.74 (s, 2H), 3.05 (t, J = 5.7 Hz,
2H), 2.89 (t, J = 5.6 Hz, 2H); 13C NMR (101 MHz, CDCl3) δ 142.40,
134.78, 134.18, 128.02, 127.96, 127.34, 126.42, 126.18, 125.46, 124.94,
75.32, 54.55, 48.63, 28.75; HRMS (ESI): [M+H]+ calcd for C22H22N+,
300.1747, found, 300.1744.
methyl 4-(benzhydrylamino)benzoate (5b): White solid, mp: 66–71 °C ,
27.2 mg (80%); 1H NMR (400 MHz, CDCl3) δ 7.80 (d, J = 8.7 Hz, 2H),
7.37 – 7.24 (m, 10H), 6.50 (d, J = 8.7 Hz, 2H), 5.58 (s, 1H), 4.67 (brs,
1H), 3.80 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 167.33, 150.95, 142.04,
131.51, 129.00, 127.78, 127.54, 119.06, 112.57, 62.53, 51.64; HRMS
(ESI): [M+Na]+ calcd for C21H19NNaO2+, 340.1308, found, 340.1303.
N-benzhydrylbenzamide (5k): White solid, mp: 158–163 °C , 16.1 mg
(56%); 1H NMR (400 MHz, CDCl3) δ 7.82 (d, J = 7.4 Hz, 2H), 7.50 (t, J =
7.3 Hz, 1H), 7.43 (t, J = 7.5 Hz, 2H), 7.38 – 7.24 (m, 10H), 6.69 (d, J =
7.2 Hz, 1H), 6.45 (d, J = 7.8 Hz, 1H); 13C NMR (101 MHz, CDCl3) δ
166.48, 141.48, 134.28, 131.69, 128.76, 128.64, 127.58, 127.51, 127.05,
57.47; HRMS (ESI): [M+Na]+ calcd for C20H17NaNO+, 310.1202, found,
310.1188.
N-benzhydryl-N-methylaniline (5c): Colorless oil, 17.7 mg (65%); 1H
NMR (400 MHz, CDCl3) δ 7.40 – 7.16 (m, 12H), 6.79 (d, J = 7.9 Hz, 2H),
6.72 (t, J = 7.2 Hz, 1H), 6.18 (s, 1H), 2.73 (s, 3H); 13C NMR (101 MHz,
CDCl3) δ 150.26, 140.79, 129.23, 128.86, 128.49, 127.30, 116.93,
113.11, 67.18, 34.63; HRMS (ESI): [M+H]+ calcd for C20H20N+, 274.1590,
found, 274.1576.
N-benzhydryl-4-methylbenzamide (5l): White solid, mp: 137–141 °C ,
18.4 mg (61%); 1H NMR (400 MHz, CDCl3) δ 7.71 (d, J = 8.0 Hz, 2H),
7.39 – 7.18 (m, 12H), 6.66 (d, J = 7.4 Hz, 1H), 6.44 (d, J = 7.8 Hz, 1H),
2.39 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 166.41, 142.14, 141.59,
131.41, 129.27, 128.73, 127.52, 127.06, 57.39, 21.46; HRMS (ESI):
[M+Na]+ calcd for C21H19NNaO+, 324.1359, found, 324.1345.
methyl 4-(benzhydryl(methyl)amino)benzoate (5d): White solid, mp:
102–105 °C , 29.5 mg (89%); 1H NMR (400 MHz, CDCl3) δ 7.89 (d, J =
9.0 Hz, 2H), 7.36 – 7.27 (m, 6H), 7.19 – 7.12 (m, 4H), 6.76 (d, J = 9.0 Hz,
2H), 6.27 (s, 1H), 3.83 (s, 3H), 2.80 (s, 3H); 13C NMR (101 MHz, CDCl3)
δ 167.44, 139.90, 131.45, 128.79, 128.71, 127.68, 117.96, 111.65, 66.72,
This article is protected by copyright. All rights reserved.